Showing results (771-780 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|May 7, 2015
Standardized classification unsuitable for spontaneous reporting: the example of osteonecrosis of the jawPaul de Boissieu, Thierry TrenqueExpert Opinion on Drug Safety|July 27, 2016
Adverse effects of oral second-line antituberculosis drugs in childrenH Simon Schaaf, Stephanie Thee, Louvina van der Laan, et al.Expert Opinion on Drug Safety|July 29, 2016
Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasonsDiogo Mendes, Carlos Alves, Francisco Batel MarquesExpert Opinion on Drug Safety|May 1, 2015
Safety of pembrolizumab for the treatment of melanomaJuan Martin-Liberal, Tiana Kordbacheh, James LarkinExpert Opinion on Drug Safety|April 16, 2020
An update on the safety of nivolumab for the treatment of advanced melanomaAnna M Czarnecka, Piotr RutkowskiExpert Opinion on Drug Safety|August 19, 2016
Cardiac safety of ophthalmic timololJukka Mäenpää, Olavi PelkonenExpert Opinion on Drug Safety|May 5, 2020
The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trialsMarie Selvy, Mélissa Cuménal, Nicolas Kerckhove, et al.Expert Opinion on Drug Safety|April 29, 2020
Safety and efficacy of idursulfase in the treatment of mucopolysaccharidosis II (Hunter syndrome): a post-marketing study in JapanKazuo Ueda, Jiro HokugoExpert Opinion on Drug Safety|August 19, 2016
Hepatotoxicity induced by coxibs: how concerned should we be?Fernando Bessone, Nelia Hernandez, Marcelo Gabriel Roma, et al.Expert Opinion on Drug Safety|June 19, 2015
Renal risk associated with sodium phosphate medication: safe in healthy individuals, potentially dangerous in othersIva Hoffmanová, Pavel Kraml, Michal AndělPageof 282